Protease Inhibitors

All categories
DBCAT000002Therapeutic categoryJ05AE

Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). A DrugBank category of 129 drugs. 58 of them are approved.

ATC classification
Part of
Enzyme Inhibitors
Also known as
Antagonists, Protease · Antiproteases · Endopeptidase Inhibitors · Hydrolase Inhibitors, Peptide · Inhibitor, Protease
Drugs

and 104 more with a free account

What you can answer from here — as of April 02, 2021

129DrugsEach linked to its full drug card
Sign in
117Drug targetsEvery drug–target pair in the class, with bond type
Sign in
18,681Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
15Routes of administrationHow the drugs in this class are given
Sign in
2SubcategoriesNarrower classes within this one
Sign in

Which targets do Protease Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In